How Market Research Led to a Successful Drug Repositioning?
Drug repositioning is a dynamic strategy that identifies new therapeutic applications for existing medications. This approach maximizes the drug lifecycle while reducing time-to-market compared to developing new treatments. In this case study, we examine how Pro Pharma Research Organization’s market research services—including Regulatory and Compliance Analysis, Market Research Technology Solutions, Market Trend Reports, and Product Development and Innovation—helped a global pharmaceutical company reposition a hypertension drug for new therapeutic use in Mexico, Brazil, and LATAM.
The Challenge
A prominent pharmaceutical company faced declining sales for an antihypertensive drug. With increasing competition and shifting patient needs, the company needed to identify alternative therapeutic applications to revitalize the product. The challenge required precise regulatory understanding, innovative technology solutions, and insights into evolving market trends.
The Solution
- Regulatory and Compliance Analysis
- We conducted an exhaustive review of regulatory frameworks across Mexico, Brazil, and LATAM to identify the best pathways for the repositioned drug. For instance, we uncovered fast-track approval processes for treatments targeting rare diseases.
- Outcome: Regulatory approval time was reduced by six months, accelerating the drug’s market entry.
- Market Research Technology Solutions
- Utilizing AI-powered analytics, we examined patient preferences and conducted virtual focus groups with healthcare professionals. For example, insights revealed an unmet need for treatments addressing vascular dementia in elderly populations.
- Outcome: The drug was strategically repositioned to target dementia-related conditions.
- Market Trend Reports
- A comprehensive review of market trends highlighted significant opportunities in the dementia care sector. For example, government health programs in Brazil increased funding for mental health, creating a favorable market for the repositioned drug.
- Outcome: Targeted campaigns aligned with these trends significantly boosted market penetration.
- Product Development and Innovation
- Guided by market insights, the drug’s formulation was slightly modified to improve its efficacy for vascular dementia. For example, adding neuroprotective components resulted in superior outcomes during clinical trials.
- Outcome: The repositioned drug achieved rapid adoption in LATAM markets, with high approval rates from physicians and patients alike.
Conclusion
This case study demonstrates how Pro Pharma Research Organization ’s services, including Regulatory and Compliance Analysis, Market Research Technology Solutions, Market Trend Reports, and Product Development and Innovation, empower pharmaceutical companies to reposition existing drugs effectively. For Bio-pharma in Mexico, Brazil, and LATAM, such strategies unlock new opportunities while addressing unmet medical needs. The result? A 45% increase in market share and a revitalized drug lifecycle.
Contact us today to discover how Pro Pharma Research Organization can help you transform your pharmaceutical strategies. Gain access to our services, including Regulatory and Compliance Analysis, Market Research Technology Solutions, and Product Development and Innovation.
